Calcium
Highest phase reached
Approved
Drug type
Small molecule
First approval year
1982
- First approval year
- 1982
- Listing at source
- Listed
- Highest phase reached
- Approved
- Drug type
- Small molecule
- Drug name
- Calcium
- Molecular weight
- 40.08
- Structure (SMILES)
These details could not be displayed.
- calcium
- Calcium
- CALCIUM [HSDB]
- CALCIUM [II]
- CALCIUM [MI]
- CALCIUM [ORANGE BOOK]
- CALCIUM [USP-RS]
- CALCIUM [VANDF]
- Calcium [WHO-DD]
- calcium hsdb
- calcium ii
- calcium mi
- calcium orange book
- calcium usp rs
- calcium vandf
- calcium who dd
- CAS registry numbers
- 7440-70-2
- ChEMBL ID
- CHEMBL1200496
- InChIKey
- OYPRJOBELJOOCE-UHFFFAOYSA-N
- PubChem compound IDs
- 5460341
- RxNorm IDs (RxCUI)
- 1895
- FDA ingredient codes (UNII)
- SY7Q814VUP
- Applicant
- GE HEALTHCARE
- Approval date
- 30 Apr 1974
- Application number
- NDA017506
- First in class
- No
- Orphan designation
- No
- Availability
- discontinued
- United States (FDA)
- Approved
- Pharmacology name
- fenoprofen
- Type
- Synthetic organic
Administration routes
- Parenteral
Mechanisms of action
- Action type
- Inhibitor
- Target
- SMCT1
- Gene symbol
- SMCT1
- Condition
- Cardiovascular Diseases
- Highest recorded phase
- 3
- Condition identifier
- EFO:0000319
- Subject identifier
- D002318
- Condition
- Hypertension
- Highest recorded phase
- 1
- Condition identifier
- EFO:0000537
- Subject identifier
- D006973
- Condition
- Wounds and Injuries
- Highest recorded phase
- 0.5
- Condition identifier
- EFO:0000546
- Subject identifier
- D014947
- Condition
- Leukemia
- Highest recorded phase
- 3
- Condition identifier
- EFO:0000565
- Subject identifier
- D007938
- Condition
- Lymphoma
- Highest recorded phase
- 3
- Condition identifier
- EFO:0000574
- Subject identifier
- D008223
- Condition
- Polycystic Ovary Syndrome
- Highest recorded phase
- 3
- Condition identifier
- EFO:0000660
- Subject identifier
- D011085
- Condition
- Pre-Eclampsia
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000668
- Subject identifier
- D011225
- Condition
- HIV Infections
- Highest recorded phase
- 0.5
- Condition identifier
- EFO:0000764
- Subject identifier
- D015658
- Condition
- Obesity
- Highest recorded phase
- 3
- Condition identifier
- EFO:0001073
- Subject identifier
- D009765
- Condition
- Coronary Disease
- Highest recorded phase
- 3
- Condition identifier
- EFO:0001645
- Subject identifier
- D003327
- Condition
- Arthritis, Juvenile
- Highest recorded phase
- 3
- Condition identifier
- EFO:0002609
- Subject identifier
- D001171
- Condition
- Pancreatic Neoplasms
- Highest recorded phase
- 2
- Condition identifier
- EFO:0002618
- Subject identifier
- D010190
- Condition
- Heart Failure
- Highest recorded phase
- 2
- Condition identifier
- EFO:0003144
- Subject identifier
- D006333
- Condition
- Vitamin D Deficiency
- Highest recorded phase
- 1
- Condition identifier
- EFO:0003762
- Subject identifier
- D014808
- Condition
- Heart Diseases
- Highest recorded phase
- 2
- Condition identifier
- EFO:0003777
- Subject identifier
- D006331
- Condition
- Dental Caries
- Highest recorded phase
- 2
- Condition identifier
- EFO:0003819
- Subject identifier
- D003731
- Condition
- Pain
- Highest recorded phase
- 3
- Condition identifier
- EFO:0003843
- Subject identifier
- D010146
- Condition
- Osteoporosis, Postmenopausal
- Highest recorded phase
- 3
- Condition identifier
- EFO:0003854
- Subject identifier
- D015663
- Condition
- Breast Neoplasms
- Highest recorded phase
- 3
- Condition identifier
- EFO:0003869
- Subject identifier
- D001943
- Condition
- Osteoporosis
- Highest recorded phase
- 3
- Condition identifier
- EFO:0003882
- Subject identifier
- D010024
- Condition
- Renal Insufficiency, Chronic
- Highest recorded phase
- 1
- Condition identifier
- EFO:0003884
- Subject identifier
- D051436
- Condition
- Fractures, Bone
- Highest recorded phase
- 3
- Condition identifier
- EFO:0003931
- Subject identifier
- D050723
- Condition
- Motor Activity
- Highest recorded phase
- 2
- Condition identifier
- EFO:0003940
- Subject identifier
- D009043
- Condition
- Hip Fractures
- Highest recorded phase
- 3
- Condition identifier
- EFO:0003964
- Subject identifier
- D006620
- Condition
- Colorectal Neoplasms
- Highest recorded phase
- 3
- Condition identifier
- EFO:0004142
- Subject identifier
- D015179
And 24 more, listed on the interactive page.
- Condition identifier
- EFO_0000275
- Condition identifier
- EFO_0000537
- Highest recorded phase
- 1
- Condition identifier
- EFO_0000546
- Highest recorded phase
- 2
- Condition identifier
- EFO_0000668
- Condition identifier
- EFO_0001073
- Highest recorded phase
- 3
- Condition identifier
- EFO_0003762
- Highest recorded phase
- 1
- Condition identifier
- EFO_0003854
- Highest recorded phase
- 3
- Condition identifier
- EFO_0003882
- Condition identifier
- EFO_0003884
- Condition identifier
- EFO_0003907
- Condition identifier
- EFO_0003940
- Highest recorded phase
- 2
- Condition identifier
- EFO_0004142
- Condition identifier
- EFO_0004723
- Condition identifier
- EFO_0009444
- Condition identifier
- EFO_0009579
- Condition identifier
- EFO_0009869
- Highest recorded phase
- 1
- Condition identifier
- HP_0000083
- Highest recorded phase
- 2
- Condition identifier
- HP_0000739
- Highest recorded phase
- 2
- Condition identifier
- HP_0000789
- Highest recorded phase
- 3
- Condition identifier
- HP_0000855
- Condition identifier
- HP_0000938
- Condition identifier
- HP_0002647
- Condition identifier
- HP_0002901
- Highest recorded phase
- 2
- Condition identifier
- HP_0003419
- Condition identifier
- HP_0004349
- Highest recorded phase
- 2
And 41 more, listed on the interactive page.
- Event
- abdominal discomfort
- Reports
- 2,535
- Reporting signal score
- 7,321.06
- Event
- alopecia
- Reports
- 2,566
- Reporting signal score
- 7,398.1
- Event
- anti-cyclic citrullinated peptide antibody positive
- Reports
- 990
- Reporting signal score
- 4,863.9
- Event
- arthralgia
- Reports
- 970
- Reporting signal score
- 849.813
- Event
- arthropathy
- Reports
- 1,486
- Reporting signal score
- 4,468.76
- Event
- asthma
- Reports
- 205
- Reporting signal score
- 158.642
- Event
- blister
- Reports
- 466
- Reporting signal score
- 910.715
- Event
- blood cholesterol increased
- Reports
- 222
- Reporting signal score
- 342.887
- Event
- c-reactive protein abnormal
- Reports
- 70
- Reporting signal score
- 142.339
- Event
- calciphylaxis
- Reports
- 74
- Reporting signal score
- 217.281
- Event
- chronic gastrointestinal bleeding
- Reports
- 10
- Reporting signal score
- 53.2676
- Event
- coma
- Reports
- 179
- Reporting signal score
- 173.213
- Event
- condition aggravated
- Reports
- 1,161
- Reporting signal score
- 1,424.39
- Event
- confusional state
- Reports
- 451
- Reporting signal score
- 379.204
- Event
- contusion
- Reports
- 333
- Reporting signal score
- 407.523
- Event
- disability
- Reports
- 72
- Reporting signal score
- 139.693
- Event
- discomfort
- Reports
- 1,273
- Reporting signal score
- 4,106.5
- Event
- drug hypersensitivity
- Reports
- 76
- Reporting signal score
- 46.6992
- Event
- drug intolerance
- Reports
- 1,420
- Reporting signal score
- 3,125.34
- Event
- duodenal ulcer perforation
- Reports
- 615
- Reporting signal score
- 2,837.94
- Event
- dyspnoea
- Reports
- 671
- Reporting signal score
- 189.183
- Event
- fatigue
- Reports
- 2,384
- Reporting signal score
- 2,777.94
- Event
- fibromyalgia
- Reports
- 118
- Reporting signal score
- 195.093
- Event
- folliculitis
- Reports
- 330
- Reporting signal score
- 1,106.18
- Event
- gastrointestinal disorder
- Reports
- 355
- Reporting signal score
- 502.681
And 69 more, listed on the interactive page.
- NCT00000402
- NCT00000426
- NCT00000611
- NCT00043719
- NCT00048061
- NCT00172172
- NCT00329797
- NCT00357643
- NCT00404820
- NCT00668941
- NCT00729183
- NCT00752557
- NCT00757393
- NCT00885170
- NCT01656512
- NCT03293108
- NCT00000415
- NCT00000543
- NCT00001304
- NCT00030238
- NCT05933499
- NCT00463268
- NCT00051636
- NCT00103740
- NCT00079001
And 48 more, listed on the interactive page.
- How often
- Twice daily
- Dry
- Wash affected area with warm water
- Prodrug
- No
- Chirality
- Achiral
- Inorganic
- Yes
- Heavy atoms
- 1
- Molecular formula
- Ca
- Monoisotopic mass
- 39.9625908
- Natural product
- Yes
- 42192-321
- 42192-323
- 58657-170
- 63629-1140
- 70518-3579
- 72162-1658
- Calcium-Regulating Hormones and Agents
Related records
Trials (64)
- A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
- Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis
- Antiepileptic Drugs and Osteoporotic Prevention Trial
- AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)
- Calcium and Bone Mass in Young Females
- Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia
- Calcium Electroporation for Urinary Bladder Tumors: A First-in-Human Feasibility, Safety, and Early Response Trial
- Calcium for Pre-Eclampsia Prevention (CPEP)
- Calcium for Prevention of Ovarian Hyperstimulation Syndrome
- Calcium Supplementation to Prevent Preeclampsia in Sichuan Province of China
- Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis
- Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)
- Effect of Calcium and Vitamin D on Bone Loss From the Hip
- Effect of Calcium Chloride on Recovery From Neuromuscular Blockade
- Effect of Extracellular Calcium on Carbetocin Mediated Contractility in Human Myometrium
- Effect of Soluble Corn Fiber Supplementation for 1 Year on Bone Metabolism in Adolescents
- Effect of Vitamin D and Calcium on Genes in the Colon
- Effect of Vitamin D Supplement in Induction of Ovulation in Overweight Women With Polycystic Ovary Syndrome
- Effectiveness of Supplemental Calcium in Preventing Postpartum Depression
- Effects of Denosumab on Bone Fusion in Osteoporotic Patients After Lumbar Fusion
In development for (61)
- Acute myeloid leukemia Phase 1
- Allergic disease Phase 3
- Anxiety Phase 2
- Bipolar disorder Phase 2
- Bone fracture Phase 3
- Bone giant cell tumor Phase 2
- Bone Paget disease Phase 3
- Breast cancer Phase 3
- Breast neoplasm Phase 3
- Cancer Phase 2
- Cardiovascular disorder Phase 3
- Chronic kidney disease Phase 1
- Colonic neoplasm Phase 3
- Colorectal adenoma Phase 3
- Colorectal cancer Phase 3
- Colorectal carcinoma Phase 3
- Colorectal neoplasm Phase 3
- Coronary artery disorder Phase 3
- Dental caries Phase 2
- Depressive disorder Phase 2